Snowball logo
logo
NYXH_logo

Nyxoah

€0.785+€0.005  (0.64%)
Estimate
EPS
-2.19
Beta
1.001
Growth
Revenue, YoY
472.76%
Net income, YoY
-59.97%
FCF, YoY
0.63%
Forecast
EPS (FWD)
-0.505
About the company
Ticker
NYXH
ISIN
BE0974358906
Country
Belgium
Sector (GICS)
Healthcare
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Frequently asked questions

What sector does Nyxoah (NYXH) operate in?

Nyxoah belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Nyxoah (NYXH) current stock price?

As of the latest data, Nyxoah stock price is €0.79, with a previous close of €0.78. Nyxoah gained €0.01 in the last trading session, representing a 0.64% increase.

What is Nyxoah (NYXH) current market capitalization?

Nyxoah market cap is approximately 79.94 million.

What is Nyxoah (NYXH) Earnings Per Share (EPS)?

The trailing EPS is -€2.19, and the forward EPS is -€0.50.

What is Nyxoah (NYXH) EBITDA?

Nyxoah EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -21.44 million.

Does Nyxoah (NYXH) pay dividends?

No. Nyxoah does not pay a dividend.

How did Nyxoah (NYXH) perform in its most recent earnings report?

In the last report (June 30, 2026), Nyxoah posted an EPS surprise of -93.33% and a revenue surprise of 1.41%.

When is Nyxoah (NYXH) next earnings report?

Nyxoah is expected to release its next earnings report on September 30, 2026.

What is Nyxoah (NYXH) beta (volatility) score?

Nyxoah has a beta of 1.001, meaning its volatility is roughly in line with the market.